Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis. Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is a key regulator of mitochondrial biogenesis and respiration [27] that plays a critical role in the control of metabolism and energy homeostasis [28-30].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [30]
In the citing paper
“hepatic gluconeogenesis was suppressed, as witnessed by decreased expression of the FoxO1-regulated genes phosphoenolpyruvate carboxykinase (Pepck) and glucose-6-phosphatase (G6P) [72].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [72]
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Self-citationCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“In contrast, insulin suppresses hepatic gluconeogenesi”
The Forkhead Transcription Factor Foxo1 Regulates Adipocyte Differentiation
Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., Arden, K. C., & Accili, D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(02)00401-x · Cited by 727
Self-citationPhosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Self-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Self-citationNakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Self-citation
Cited by
Items 201–300 of 1,000
Nagai, Y., Yonemitsu, S., Erion, D. M., Iwasaki, T., Stark, R., Weismann, D., Dong, J., Zhang, D., Jurczak, M. J., Löffler, M. G., et al. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.01.011 · Cited by 203
“Through these interactions, they can coordinate both hepatic glucose and lipid metabolism, the former via forkhead transcription factor-1 (FOXO1) (Puigserver et al., 2003); hepatocyte nuclear factor 4 alpha (HNF4a) (Rhee et al., 2003) and myocyte enhancer factor-2 (MEF-2) (Michael et al., 2001),…”
BackgroundKetogenesis-generated β-hydroxybutyrate is an epigenetic regulator of CD8+ T-cell memory development
Zhang, H., Tang, K., Ma, J., Zhou, L., Liu, J., Zeng, L., Zhu, L., Xu, P., Chen, J., Wei, K., et al. (2020) · Nature Cell Biology · doi:10.1038/s41556-019-0440-0 · Cited by 204
Steinbrenner, H., Speckmann, B., Pinto, A., & Sies, H. (2010) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.11-002fr · Cited by 202
Yan, F., Dai, G., & Zheng, X. (2016) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2016.07.004 · Cited by 198
“Furthermore, there is alsoan interactionbetweenPGC-1α andFOXO1 in the performance of insulin-regulated gluconeogenesis [35].”
BackgroundPKA-dependent regulation of the histone lysine demethylase complex PHF2–ARID5B
Baba, A., Ohtake, F., Okuno, Y., Yokota, K., Okada, M., Imai, Y., Ni, M., Meyer, C. A., Igarashi, K., Kanno, J., et al. (2011) · Nature Cell Biology · doi:10.1038/ncb2228 · Cited by 199
Targeting cAMP/PKA pathway for glycemic control and type 2 diabetes therapy
Yang, H., & Yang, L. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-15-0316 · Cited by 203
Miao, J., Fang, S., Bae, Y., & Kemper, J. K. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510713200 · Cited by 200
Metformin suppresses hepatic gluconeogenesis through induction of SIRT1 and GCN5
Caton, P. W., Nayuni, N. K., Kieswich, J., Khan, N. Q., Yaqoob, M. M., & Corder, R. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0345 · Cited by 198
“Once activated, PGC1a forms a complex with the transcription factors Foxo1 and hepatic nuclear factor 4a (Hnf4a or Hnf4a), leading to the induction of gluconeogenic genes including Pck1 (Yoon et al. 2001, Puigserver et al. 2003, Rhee et al. 2003).”
BackgroundSelective Inhibition of FOXO1 Activator/Repressor Balance Modulates Hepatic Glucose Handling
Langlet, F., Haeusler, R. A., Lindén, D., Ericson, E., Norris, T., Johansson, A., Cook, J. R., Aizawa, K., Wang, L., Buettner, C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.045 · Cited by 197
“PGC-1a (Matsumoto et al., 2007; Puigserver et al., 2003) and PRMTs (Choi et al., 2012) are known transcriptional co-activators of FOXO1-dependent gluconeogenesis.”
Self-citationHumphrey, J. S., Price, K., Gupta, E., Baxter, A., Bird, J., Sonnichsen, D., & Naglich, J. (2003) · Chemoradiation in Cancer Therapy · doi:10.1007/978-1-59259-325-5_21 · Cited by 193
Hepatocyte CYP2E1 overexpression and steatohepatitis lead to impaired hepatic insulin signaling
Schattenberg, J. M., Wang, Y., Singh, R., Rigoli, R. M., & Czaja, M. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410310200 · Cited by 194
FOXO3 induces FOXO1-dependent autophagy by activating the AKT1 signaling pathway
Zhou, J., Liao, W., Yang, J., Ma, K., Li, X., Wang, Y., Wang, D., Wang, L., Zhang, Y., Yin, Y., et al. (2012) · Autophagy · doi:10.4161/auto.21830 · Cited by 192
Systematic Analysis of Protein Phosphorylation Networks From Phosphoproteomic Data
Song, C., Ye, M., Liu, Z., Cheng, H., Jiang, X., Han, G., Songyang, Z., Tan, Y., Wang, H., Ren, J., et al. (2012) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.012625 · Cited by 197
Dominy, J. E., Lee, Y., Gerhart-Hines, Z., & Puigserver, P. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.023 · Cited by 192
Self-citationRegulation of Hepatic Gluconeogenesis by an ER-Bound Transcription Factor, CREBH
Lee, M.-W., Chanda, D., Yang, J., Oh, H., Kim, S. S., Yoon, Y.-S., Hong, S., Park, K.-G., Lee, I.-K., Choi, C. S., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.02.016 · Cited by 194
“Elevation of PGC-1a expression is displayed in mouse models of type II diabetes, and its liver-specific ablation markedly affects glycemic profiles in mice, showing the importance of this factor in the regulation of hepatic glucose metabolism (Herzig et al., 2001; Koo et al., 2004; Leone et al., 2005; Lin et al., 2004…”
InfluentialEnforced PGC-1α expression promotes CD8 T cell fitness, memory formation and antitumor immunity
Dumauthioz, N., Tschumi, B., Wenes, M., Marti, B., Wang, H., Franco, F., Li, W., Lopez-Mejia, I. C., Fajas, L., Ho, P.-C., et al. (2021) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0365-3 · Cited by 187
Jeninga, E. H., Schoonjans, K., & Auwerx, J. (2010) · Oncogene · doi:10.1038/onc.2010.206 · Cited by 193
“…to the regulation of its expression level, PGC1a activity is controlled by a variety of posttranslational modifications, including phosphorylation (Puigserver et al., 2003; Jager et al., 2007; Li et al., 2007), ubiquitination (Olson et al., 2008) and acetylation (Rodgers et al., 2005; Lerin et…”
BackgroundJitrapakdee, S. (2012) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2011.10.001 · Cited by 195
Kurlawalla-Martinez, C., Stiles, B., Wang, Y., Devaskar, S. U., Kahn, B. B., & Wu, H. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.6.2498-2510.2005 · Cited by 191
PPAR control: it's SIRTainly as easy as PGC
Sugden, M. C., Caton, P. W., & Holness, M. J. (2010) · Journal of Endocrinology · doi:10.1677/joe-09-0359 · Cited by 192
Serine-arginine protein kinases: a small protein kinase family with a large cellular presence
Giannakouros, T., Nikolakaki, E., Mylonis, I., & Georgatsou, E. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2010.07987.x · Cited by 188
Kang, S., Dahl, R., Hsieh, W., Shin, A., Zsebo, K. M., Buettner, C., Hajjar, R. J., & Lebeche, D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.705012 · Cited by 189
The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications
Tan, Z., Luo, X., Xiao, L., Tang, M., Bode, A. M., Dong, Z., & Cao, Y. (2016) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-15-0621 · Cited by 189
Forkhead Transcription Factor FoxO1 in Adipose Tissue Regulates Energy Storage and Expenditure
Nakae, J., Cao, Y., Oki, M., Orba, Y., Sawa, H., Kiyonari, H., Iskandar, K., Suga, K., Lombes, M., & Hayashi, Y. (2008) · Diabetes · doi:10.2337/db07-0698 · Cited by 187
Ahmed, M. H., & Byrne, C. D. (2007) · Drug Discovery Today · doi:10.1016/j.drudis.2007.07.009 · Cited by 186
Kathirvel, E., Morgan, K., Nandgiri, G., Sandoval, B. C., Caudill, M. A., Bottiglieri, T., French, S. W., & Morgan, T. R. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00249.2010 · Cited by 186
FoxOs Function Synergistically to Promote Glucose Production
Haeusler, R. A., Kaestner, K. H., & Accili, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.c110.175851 · Cited by 186
Self-citationNrf2 Represses FGF21 During Long-Term High-Fat Diet–Induced Obesity in Mice
Chartoumpekis, D. V., Ziros, P. G., Psyrogiannis, A. I., Papavassiliou, A. G., Kyriazopoulou, V. E., Sykiotis, G. P., & Habeos, I. G. (2011) · Diabetes · doi:10.2337/db11-0112 · Cited by 184
Characterization of the direct targets of FOXO transcription factors throughout evolution
Webb, A. E., Kundaje, A., & Brunet, A. (2016) · Aging Cell · doi:10.1111/acel.12479 · Cited by 182
“This finding is consistent with FOXO’s ability to open compacted chromatin (Zaret & Carroll, 2011), interact with chromatin remodeling factors (Riedel et al., 2013), and regulate glucose metabolism (Puigserver et al., 2003; Matsumoto et al., 2007).”
Adachi, M., & Brenner, D. A. (2008) · Hepatology · doi:10.1002/hep.21991 · Cited by 181
Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis
Valenti, L., Rametta, R., Dongiovanni, P., Maggioni, M., Ludovica Fracanzani, A., Zappa, M., Lattuada, E., Roviaro, G., & Fargion, S. (2008) · Diabetes · doi:10.2337/db07-0714 · Cited by 187
Adaptation to fasting by glycerol transport through aquaporin 7 in adipose tissue
Maeda, N., Funahashi, T., Hibuse, T., Nagasawa, A., Kishida, K., Kuriyama, H., Nakamura, T., Kihara, S., Shimomura, I., & Matsuzawa, Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406230101 · Cited by 178
The FoxO transcription factors and metabolic regulation
Nakae, J., Oki, M., & Cao, Y. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.025 · Cited by 176
“In contrast, a dominant negative FoxO1 (aa1–256), which has no transactivation domain, inhibits PGC-1a-induced gene expression of G6pc and Pck1 [76].”
BackgroundHepatic Suppression of Foxo1 and Foxo3 Causes Hypoglycemia and Hyperlipidemia in Mice
Zhang, K., Li, L., Qi, Y., Zhu, X., Gan, B., DePinho, R. A., Averitt, T., & Guo, S. (2012) · Endocrinology · doi:10.1210/en.2011-1527 · Cited by 179
“Other factors that can interact with Foxo1 include cAMP response element-binding protein/p300 (42), CCAAT/enhancer-binding protein- (43), and Pgc1 (44).”
BackgroundInfluentialSamuel, V. T., Choi, C. S., Phillips, T. G., Romanelli, A. J., Geisler, J. G., Bhanot, S., McKay, R., Monia, B., Shutter, J. R., Lindberg, R. A., et al. (2006) · Diabetes · doi:10.2337/db05-0705 · Cited by 177
Wnt Signaling Regulates Hepatic Metabolism
Liu, H., Fergusson, M. M., Wu, J. J., Rovira, I. I., Liu, J., Gavrilova, O., Lu, T., Bao, J., Han, D., Sack, M. N., et al. (2011) · Science Signaling · doi:10.1126/scisignal.2001249 · Cited by 174
Steinbrenner, H. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.07.016 · Cited by 172
Hepatic insulin signalling is dispensable for suppression of glucose output by insulin in vivo
Titchenell, P. M., Chu, Q., Monks, B. R., & Birnbaum, M. J. (2015) · Nature Communications · doi:10.1038/ncomms8078 · Cited by 169
Accili, D. (2004) · Diabetes · doi:10.2337/diabetes.53.7.1633 · Cited by 169
Self-citationRegulation of FOXO Factors in Mammalian Cells
Brown, A. K., & Webb, A. E. (2018) · Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2017.10.006 · Cited by 168
“…FOXOs regulate a number of target genes involved in energy metabolism, including the gluconeogenic enzymes glucose-6-phosphatase (G6Pase), phosphoenolpyruvate carboxykinase (Pepck), and (PGC1a) (Altomonte et al., 2003; Matsumoto, Pocai, Rossetti, Depinho, & Accili, 2007; Puigserver et al., 2003).”
BackgroundPlant-Based Antidiabetic Nanoformulations: The Emerging Paradigm for Effective Therapy
Dewanjee, S., Chakraborty, P., Mukherjee, B., & De Feo, V. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21062217 · Cited by 162
Adams, C. M. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m610510200 · Cited by 169
PGC-1α, a Key Modulator of p53, Promotes Cell Survival upon Metabolic Stress
Sen, N., Satija, Y. K., & Das, S. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.044 · Cited by 166
“…involved in the control of cellular metabolism including PPARg (Puigserver et al., Molec 1998), NRF-1 (Wu et al., 1999), NRF-2 (Wu et al., 1999), FOXO1 (Puigserver et al., 2003), etc. Emerging data suggest that p53 plays an important role in regulating cellular metabolism (Vousden and Ryan, 2009).”
InfluentialAutophagy Regulates the Liver Clock and Glucose Metabolism by Degrading CRY1
Toledo, M., Batista-Gonzalez, A., Merheb, E., Aoun, M. L., Tarabra, E., Feng, D., Sarparanta, J., Merlo, P., Botrè, F., Schwartz, G. J., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.05.023 · Cited by 167
“…M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript drives gluconeogenesis during reduced feeding when insulin levels are low (Puigserver et al., 2003), and because CRY1 participates in the degradation of nuclear FoxO1 (Jang et al., 2016), we tested whether decreased…”
BackgroundMitochondrial Dysfunction in Diabetic Neuropathy: a Series of Unfortunate Metabolic Events
Fernyhough, P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-015-0671-9 · Cited by 164
PGC-1α in aging and anti-aging interventions
Anderson, R., & Prolla, T. (2009) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2009.04.005 · Cited by 162
Laganière, J., Tremblay, G. B., Dufour, C. R., Giroux, S., Rousseau, F., & Giguère, V. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313543200 · Cited by 167
Role of ChREBP in hepatic steatosis and insulin resistance
Denechaud, P.-D., Dentin, R., Girard, J., & Postic, C. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.07.084 · Cited by 163
Hallberg, M., Morganstein, D. L., Kiskinis, E., Shah, K., Kralli, A., Dilworth, S. M., White, R., Parker, M. G., & Christian, M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00504-08 · Cited by 164
“PGC-1 is a coactivator for a number of other NRs, including ERR and transcription factors such as Foxo1A, SREBP, and NRF-1 (34, 42 , 47).”
BackgroundMitochondrial Roles and Cytoprotection in Chronic Liver Injury
Degli Esposti, D., Hamelin, J., Bosselut, N., Saffroy, R., Sebagh, M., Pommier, A., Martel, C., & Lemoine, A. (2012) · Biochemistry Research International · doi:10.1155/2012/387626 · Cited by 158
“PGC-1 alpha is present at low but inducible levels in the liver where it also regulates most of the metabolic pathways, including gluconeogenesis, fatty acid β-oxidation, ketogenesis and heme biosynthesis (Figure 4) [90–93].”
Burgermeister, E., Schnoebelen, A., Flament, A., Benz, J., Stihle, M., Gsell, B., Rufer, A., Ruf, A., Kuhn, B., Märki, H. P., et al. (2006) · Molecular Endocrinology · doi:10.1210/me.2005-0171 · Cited by 160
The role of insulin and IGF-1 signaling in longevity
Katic, M., & Kahn, C. R. (2005) · CMLS Cellular and Molecular Life Sciences · doi:10.1007/s00018-004-4297-y · Cited by 159
Wesolowski, S. R., Regnault, T. R. H., Brown, L. D., Rozance, P. J., Keng, J. A., Roper, M. D., Wilkening, R. B., Hay, W. W., & Friedman, J. E. (2009) · Endocrinology · doi:10.1210/en.2008-1789 · Cited by 174
Ginsenoside Rg1 Inhibits Glucagon-Induced Hepatic Gluconeogenesis through Akt-FoxO1 Interaction
Liu, Q., Zhang, F.-G., Zhang, W., Pan, A., Yang, Y., Liu, J., Li, P., Liu, B., & Qi, L. (2017) · Theranostics · doi:10.7150/thno.18788 · Cited by 158
The circulating metabolome of human starvation
Steinhauser, M. L., Olenchock, B. A., O’Keefe, J., Lun, M., Pierce, K. A., Lee, H., Pantano, L., Klibanski, A., Shulman, G. I., Clish, C. B., et al. (2018) · JCI Insight · doi:10.1172/jci.insight.121434 · Cited by 152
Bastie, C. C., Nahlé, Z., McLoughlin, T., Esser, K., Zhang, W., Unterman, T., & Abumrad, N. A. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413625200 · Cited by 159
Nuclear receptors, mitochondria and lipid metabolism
Alaynick, W. A. (2008) · Mitochondrion · doi:10.1016/j.mito.2008.02.001 · Cited by 159
Kwon, H.-S., Huang, B., Unterman, T. G., & Harris, R. A. (2004) · Diabetes · doi:10.2337/diabetes.53.4.899 · Cited by 158
Pearen, M. A., Myers, S. A., Raichur, S., Ryall, J. G., Lynch, G. S., & Muscat, G. E. O. (2008) · Endocrinology · doi:10.1210/en.2007-1202 · Cited by 158
“Furthermore, we observed that 2-AR agonist administration in mouse skeletal muscle induced the expression of genes that activate fatty acid oxidation and modulate pyruvate use, including PGC-1 , lipin-1 , FOXO1, and PDK4.”
BackgroundInfluentialHippo Signaling: Key Emerging Pathway in Cellular and Whole-Body Metabolism
Ardestani, A., Lupse, B., & Maedler, K. (2018) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2018.04.006 · Cited by 160
Estrogen-related Receptors Stimulate Pyruvate Dehydrogenase Kinase Isoform 4 Gene Expression
Zhang, Y., Ma, K., Sadana, P., Chowdhury, F., Gaillard, S., Wang, F., McDonnell, D. P., Unterman, T. G., Elam, M. B., & Park, E. A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608657200 · Cited by 159
Role of Forkhead Box O (FOXO) transcription factor in aging and diseases
Tia, N., Singh, A. K., Pandey, P., Azad, C. S., Chaudhary, P., & Gambhir, I. S. (2018) · Gene · doi:10.1016/j.gene.2018.01.051 · Cited by 158
MicroRNA 33 Regulates Glucose Metabolism
Ramírez, C. M., Goedeke, L., Rotllan, N., Yoon, J.-H., Cirera-Salinas, D., Mattison, J. A., Suárez, Y., de Cabo, R., Gorospe, M., & Fernández-Hernando, C. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00016-13 · Cited by 154
Self-citationYuan, M., Pino, E., Wu, L., Kacergis, M., & Soukas, A. A. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.386854 · Cited by 154
Liu, Z., Rudd, M. D., Hernandez-Gonzalez, I., Gonzalez-Robayna, I., Fan, H.-Y., Zeleznik, A. J., & Richards, J. S. (2009) · Molecular Endocrinology · doi:10.1210/me.2008-0412 · Cited by 154
The emerging role of FOXO transcription factors in pancreatic β cells
Glauser, D. A., & Schlegel, W. (2007) · Journal of Endocrinology · doi:10.1677/joe-06-0191 · Cited by 153
“There is evidence for this notably in liver (Puigserver et al. 2003), muscle (Furuyama et al.”
BackgroundInsulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein
Zhou, X., Shibusawa, N., Naik, K., Porras, D., Temple, K. A., Ou, H., Kaihara, K. A., Roe, M. W., Brady, M., & Wondisford, F. E. (2004) · Nature Medicine · doi:10.1038/nm1050 · Cited by 160
“PGC-1α (encoded by the gene Ppargc1a ) functions as a central regulator of gluconeogenesis by binding to several factors, including the glucocorticoid receptor, hepatic nuclear factor 4α and a forkhead transcription factor (FOXO1) upstream of several genes encoding gluconeogenic enzyme”
BackgroundDing, X., Lichti, K., Kim, I., Gonzalez, F. J., & Staudinger, J. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600931200 · Cited by 151
Renal Gluconeogenesis: An Underestimated Role of the Kidney in Systemic Glucose Metabolism
Legouis, D., Faivre, A., Cippà, P. E., & de Seigneux, S. (2022) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaa302 · Cited by 151
Vander Kooi, B. T., Onuma, H., Oeser, J. K., Svitek, C. A., Allen, S. R., Vander Kooi, C. W., Chazin, W. J., & O’Brien, R. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0497 · Cited by 153
“Similarly, combined glucocorticoid and cAMP treatment has been shown to stimulate FKHR binding to the PEPCK and G6Pase promoters, whereas insulin treatment has been shown to decrease FKHR binding (83).”
Mitochondria and PGC-1α in Aging and Age-Associated Diseases
Wenz, T. (2011) · Journal of Aging Research · doi:10.4061/2011/810619 · Cited by 148
“PGC1α associates in liver with several transcription factors such as HNF4-α and FoxO1 and thereby induces the expression of several gluconeogenic enzymes [100, 101].”
BackgroundPKCδ regulates hepatic insulin sensitivity and hepatosteatosis in mice and humans
Bezy, O., Tran, T. T., Pihlajamäki, J., Suzuki, R., Emanuelli, B., Winnay, J., Mori, M. A., Haas, J., Biddinger, S. B., Leitges, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci46045 · Cited by 147
Lavoie, J.-M., & Gauthier, M. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6600-y · Cited by 177
Alternative mRNA Splicing Produces a Novel Biologically Active Short Isoform of PGC-1α
Zhang, Y., Huypens, P., Adamson, A. W., Chang, J. S., Henagan, T. M., Boudreau, A., Lenard, N. R., Burk, D., Klein, J., Perwitz, N., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.037556 · Cited by 148
LIM, J., Lee, H., HOJUNG, M., & Song, J. (2008) · Cellular Signalling · doi:10.1016/j.cellsig.2008.10.004 · Cited by 168
Hepatic mTORC1 controls locomotor activity, body temperature, and lipid metabolism through FGF21
Cornu, M., Oppliger, W., Albert, V., Robitaille, A. M., Trapani, F., Quagliata, L., Fuhrer, T., Sauer, U., Terracciano, L., & Hall, M. N. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1412047111 · Cited by 152
Glucocorticoid-Induced Fatty Liver Disease
Rahimi, L., Rajpal, A., & Ismail-Beigi, F. (2020) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s247379 · Cited by 144
Prevention of Steatosis by Hepatic JNK1
Sabio, G., Cavanagh-Kyros, J., Ko, H. J., Jung, D. Y., Gray, S., Jun, J. Y., Barrett, T., Mora, A., Kim, J. K., & Davis, R. J. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.09.007 · Cited by 148
“Indeed, the liver of LKO mice ex- pressed increased amounts of PGC-1a (Figure S6), a coactivator of the gluconeogenic gene transcription factors HNF4a and FOXO1 (Puigserver et al., 2003; Yoon et al., 2001).”
BackgroundObesity and cancer, a case for insulin signaling
Poloz, Y., & Stambolic, V. (2015) · Cell Death and Disease · doi:10.1038/cddis.2015.381 · Cited by 165
Estall, J. L., Kahn, M., Cooper, M. P., Fisher, F. M., Wu, M. K., Laznik, D., Qu, L., Cohen, D. E., Shulman, G. I., & Spiegelman, B. M. (2009) · Diabetes · doi:10.2337/db08-1571 · Cited by 148
Self-citationTaniguchi, C. M., Finger, E. C., Krieg, A. J., Wu, C., Diep, A. N., LaGory, E. L., Wei, K., McGinnis, L. M., Yuan, J., Kuo, C. J., et al. (2013) · Nature Medicine · doi:10.1038/nm.3294 · Cited by 149
Deng, X., Zhang, W., O-Sullivan, I., Williams, J. B., Dong, Q., Park, E. A., Raghow, R., Unterman, T. G., & Elam, M. B. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.347211 · Cited by 147
“SREBP-1c expression was increased in livers of transgenic mice with liver-specific triple deletion of FoxO1, FoxO3, and FoxO4 (4).”
BackgroundInfluentialSuppression of β Cell Energy Metabolism and Insulin Release by PGC-1α
Yoon, J. C., Xu, G., Deeney, J. T., Yang, S.-N., Rhee, J., Puigserver, P., Levens, A. R., Yang, R., Zhang, C.-Y., Lowell, B. B., et al. (2003) · Developmental Cell · doi:10.1016/s1534-5807(03)00170-9 · Cited by 143
Self-citationRole of histone and transcription factor acetylation in diabetes pathogenesis
Gray, S. G., & De Meyts, P. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.559 · Cited by 144
Sirtuins and Insulin Resistance
Zhou, S., Tang, X., & Chen, H.-Z. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00748 · Cited by 142
Aharoni-Simon, M., Hahn-Obercyger, M., Pen, S., Madar, Z., & Tirosh, O. (2011) · Laboratory Investigation · doi:10.1038/labinvest.2011.55 · Cited by 169
“PEPCK is an important gluconeogenic enzyme in the liver, whose expression is regulated by PGC1 α -induced coactivation of the forkhead box O1 (FOXO1) transcription factor”
BackgroundPGC-1α: a potent transcriptional cofactor involved in the pathogenesis of type 2 diabetes
Soyal, S. M., Krempler, F., Oberkofler, H., & Patsch, W. (2006) · Diabetologia · doi:10.1007/s00125-006-0268-6 · Cited by 162
“As shown in mice, it is required for the interaction of PGC-1α with FOXO1 and HNF4α, both of which contribute to the regulation of gluconeogenic target genes [18, 21 ].”
BackgroundInfluentialGenetic determinants of hepatic steatosis in man
Hooper, A. J., Adams, L. A., & Burnett, J. R. (2011) · Journal of Lipid Research · doi:10.1194/jlr.r008896 · Cited by 142
Upregulation of lncRNA MEG3 promotes hepatic insulin resistance via increasing FoxO1 expression
Zhu, X., Wu, Y., Zhou, J., & Kang, D. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.11.048 · Cited by 153
MuRF1/TRIM63, Master Regulator of Muscle Mass
Peris-Moreno, D., Taillandier, D., & Polge, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186663 · Cited by 155
“PGC1-alpha is a transcriptional co-activator known to interact with FoxO1 in liver, which promotes the transcription of genes important for gluconeogenesis [64].”
The Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis
Liang, C.-P., Han, S., Senokuchi, T., & Tall, A. R. (2007) · Circulation Research · doi:10.1161/circresaha.107.152165 · Cited by 143
Chen, M., Gavrilova, O., Zhao, W.-Q., Nguyen, A., Lorenzo, J., Shen, L., Nackers, L., Pack, S., Jou, W., & Weinstein, L. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24196 · Cited by 141
Figueroa‐Soto, C. G., & Valenzuela-Soto, E. M. (2018) · Biochimie · doi:10.1016/j.biochi.2018.01.002 · Cited by 153
Connaughton, S., Chowdhury, F., Attia, R. R., Song, S., Zhang, Y., Elam, M. B., Cook, G. A., & Park, E. A. (2010) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.08.011 · Cited by 144
Glucose Metabolism Abnormalities in Cushing Syndrome: From Molecular Basis to Clinical Management
Scaroni, C., Zilio, M., Foti, M., & Boscaro, M. (2017) · Endocrine Reviews · doi:10.1210/er.2016-1105 · Cited by 140
FoxO6 Integrates Insulin Signaling With Gluconeogenesis in the Liver
Kim, D. H., Perdomo, G., Zhang, T., Slusher, S., Lee, S., Phillips, B. E., Fan, Y., Giannoukakis, N., Gramignoli, R., Strom, S. C., et al. (2011) · Diabetes · doi:10.2337/db11-0548 · Cited by 143
Self-citationAlkhalidy, H., Moore, W., Wang, A., Luo, J., McMillan, R. P., Wang, Y., Wei, Z. C., Hulver, M. W., & Liu, D. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.04.014 · Cited by 157
Genetic evidence points to an osteocalcin-independent influence of osteoblasts on energy metabolism
Yoshikawa, Y., Kode, A., Xu, L., Mosialou, I., Silva, B. C., Ferron, M., Clemens, T. L., Economides, A. N., & Kousteni, S. (2011) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.417 · Cited by 140
Diabetic cardiomyopathy: mechanisms and therapeutic targets
Battiprolu, P. K., Gillette, T. G., Wang, Z. V., Lavandero, S., & Hill, J. A. (2010) · Drug Discovery Today Disease Mechanisms · doi:10.1016/j.ddmec.2010.08.001 · Cited by 160
Tao, R., Wei, D., Gao, H., Liu, Y., DePinho, R. A., & Dong, X. C. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.201061 · Cited by 143
Metadata
- Authors
- Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Columbia University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2003-05-18
- Volume
- 423
- Issue
- 6939
- Pages
- 550-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1583767403
- Cited by
- 1,487
- References
- 22
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 46 · 2023: 53 · 2022: 62 · 2021: 67 · 2020: 71 · 2019: 61 · 2018: 86 · 2017: 76 · 2016: 59 · 2015: 75 · 2014: 71 · 2013: 68 · 2012: 81
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Taiho Pharmaceutical
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- hepatic gluconeogenesis, insulin signaling, FOXO1, PGC-1α, transcriptional coactivation, Akt phosphorylation, fasting, diabetes mellitus, glucocorticoids, glucagon, gluconeogenic gene expression, hepatocytes, forkhead transcription factor
- MeSH terms
- Forkhead Box Protein O1, Animals, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Gluconeogenesis, Insulin, Liver, Precipitin Tests, Protein Binding, RNA, Messenger, Transcription Factors, Hepatocytes, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.